F-18 FDG PET/CT for detection of malignant involvement of peripheral nerves: Case series and literature review

Clinical Nuclear Medicine

Volumn 36, Issue 2, 2011, Pages 96-100

  Bronstein, Yulia ^a   Tummala, Sudhakar ^a   Rohren, Eric ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

F 18 FDG PET CT; malignant involvement; MRI correlation; peripheral nerves

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER DIAGNOSIS; CLINICAL ARTICLE; COLON CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; FOLLOW UP; HUMAN; LUNG CANCER; LYMPHOMA; MALE; MEDICAL RECORD REVIEW; MELANOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIPHERAL NERVE TUMOR; POSITRON EMISSION TOMOGRAPHY; TUMOR DIFFERENTIATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHOMA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 79551603799     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e318203bb0e     Document Type: Article

References (25)

1. Hathaway PB, Mankoff DA, Maravilla KR, et al. Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast cancer: preliminary experience. Radiology. 1999;210:807-814.
2. Bokstein F, Goor O, Shihman B, et al. Assessment of neurolymphomatosis by brachial plexus biopsy and PET/CT. Report of a case. J Neurooncol. 2005; 72:163-167.
3. Lin M, Kilanowska J, Taper J, et al. Neurolymphomatosis\diagnosis and assessment of treatment response by FDG PET-CT. Hematol Oncol. 2008; 26:43-45.
4. Rosso SM, de Bruin HG, Wu KL, et al. Diagnosis of neurolymphomatosis with FDG PET. Neurology. 2006;67:722-723.
5. von Falck C, Rodt T, Joerdens S, et al. F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound. Clin Nucl Med. 2009;34:493-495.
6. Kanter P, Zeidman A, Streifler J, et al. PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis. Eur J Haematol. 2005;74:66-69.
7. Kim JH, Jang JH, Koh SB. A case of neurolymphomatosis involving cranial nerves: MRI and fusion PET-CT findings. J Neurooncol. 2006;80:209-210.
8. Bajrovic A, Rades D, Fehlauer F, et al. Is there a life-long risk ofbrachial plexopathy after radiotherapy of supraclavicular lymph nodes in breast cancer patients? Radiother Oncol. 2004;71:297-301.
9. Fathers E, Thrush D, Huson SM, et al. Radiation-induced brachial plexopathy in women treated for carcinoma of the breast Clin Rehabil. 2002;16:160-165.
10. Galecki J, Hicer-Grzenkowicz J, Grudzien-Kowalska M, et al. Radiation-induced brachial plexopathy and hypofractionated regimens in adjuvant irradiation of patients with breast cancer\a review. Acta Oncol. 2006;45:280-284.
11. Pierce SM, Recht A, Lingos TI, et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys. 1992;23:915-923.
12. Castagno AA, Shuman WP. MR imaging in clinically suspected brachial plexus tumor. Am J Roentgenol. 1987;149:1219-1222.
13. Iyer RB, Fenstermacher MJ, Libshitz HI. MR imaging of the treated brachial plexus. Am J Roentgenol. 1996;167:225-229.
14. Qayyum A, MacVicar AD, Padhani AR, et al. Symptomatic brachial plex-opathy following treatment for breast cancer: utility of MR imaging with surface-coil techniques. Radiology. 2000;214:837-842.
15. Fishman EK, Campbell JN, Kuhlman JE, et al. Multiplanar CT evaluation of brachial plexopathy inbreast cancer. J Comput Assist Tomogr. 1991;15:790-795.
16. Ahmad A, Barrington S, Maisey M, et al. Use of positron emission tomog-raphy in evaluation of brachial plexopathy in breast cancer patients. Br J Cancer. 1999;79:478-482.
17. Hughes RA, Britton T, Richards M. Effects of lymphoma on the peripheral nervous system. JR Soc Med. 1994;87:526-530.
18. Levin N, Soffer D, Grissaru S, et al. Primary T-cell CNS lymphoma presenting with leptomeningeal spread and neurolymphomatosis. J Neuroon-col. 2008;90:77-83.
19. Misdraji J, Ino Y, Louis DN, et al. Primary lymphoma ofperipheral nerve: report of four cases. Am J Surg Pathol. 2000;24:1257-1265.
20. Boes M, Pels H, Klockgether T, et al. High-grade B-cell NHL of the brachial plexus followed by infiltration of the spinal cord. J Neurol. 2008;255:135-137.
21. Pels H, Deckert-Schluter M, Glasmacher A, et al. Primary central nervous system lymphoma: a clinicopathological study of 28 cases. Hematol Oncol. 2000;18:21-32.
22. Pels H, Juergens A, Glasmacher A, et al. Early relapses in primary CNS lymphoma after response to polychemotherapy without intraventricular treat-ment: results of a phase II study. J Neurooncol. 2009;91:299-305.
23. Trojan A, Jermann M, Taverna C, et al. Fusion PET-CT imaging of neu-rolymphomatosis. Ann Oncol. 2002;13:802-805.
24. Strobel K, Fischer K, Hany TF, et al. Sciatic nerve neurolymphomatosis\ extent and therapy response assessment with PET/CT. Clin Nucl Med. 2007;32:646-648.
25. Strobel K, Pestalozzi B, Ciernik I, et al. Changing PET/CT manifestation of neurolymphomatosis. Eur J Nucl Med Mol Imaging. 2006;33:1244.